Medications received by patients with juvenile dermatomyositis-Reference-Cited by-同舟云学术

Medications received by patients with juvenile dermatomyositis

Published:2018-12 Issue:3 Volume:48 Page:513-522
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Kishi Takayuki,Bayat Nastaran,Ward Michael M.,Huber Adam M.^ORCID,Wu Lan,Mamyrova Gulnara,Targoff Ira N.,Warren-Hicks William J.,Miller Frederick W.,Rider Lisa G.

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference40 articles.

1. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood;Feldman;Lancet,2008

2. The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes;Rider;J Intern Med,2016

3. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies;Rider;Rheum Dis Clin North Am,2013

4. Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort;Tansley;J Autoimmun,2017

5. Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification;Bowyer;J Pediatr,1983

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Juvenile Dermatomyositis: Pathophysiology, Diagnosis, Treatment and Interstitial Lung Diseases—A Narrative Review;Children;2024-08-27

2. Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy;Arthritis & Rheumatology;2023-06-07

3. Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance;Pediatric Rheumatology;2023-01-06

4. Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features;Rheumatology;2022-08-12

5. Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management;Current Pediatric Reviews;2021-12